IMPORTANT EQUITY ALERT: Lundin Law PC Announces an Investigation of Diplomat Pharmacy, Inc. and Advises Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at brian@lundinlawpc.com.

The investigation focuses on whether Diplomat and certain of its officers and/or directors violated federal securities laws. On November 2, 2016, Diplomat announced third quarter 2016 results that fell below investors’ expectations. The Company also lowered its full year 2016 guidance.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.